165 related articles for article (PubMed ID: 23402476)
1. Comparison of the effect of combination therapy with an angiotensin II receptor blocker and either a low-dose diuretic or calcium channel blocker on cardiac hypertrophy in patients with hypertension.
Okura T; Miyoshi K; Irita J; Enomoto D; Jotoku M; Nagao T; Watanabe K; Matsuoka H; Ashihara T; Higaki J;
Clin Exp Hypertens; 2013; 35(8):563-9. PubMed ID: 23402476
[TBL] [Abstract][Full Text] [Related]
2. Effect of Diuretic or Calcium-Channel Blocker Plus Angiotensin-Receptor Blocker on Diastolic Function in Hypertensive Patients.
Toh N; Ishii K; Kihara H; Iwakura K; Watanabe H; Yoshikawa J; Ito H;
Circ J; 2016; 80(2):426-34. PubMed ID: 26725762
[TBL] [Abstract][Full Text] [Related]
3. Ambulatory blood pressure response to triple therapy with an angiotensin-receptor blocker (ARB), calcium-channel blocker (CCB), and HCTZ versus dual therapy with an ARB and HCTZ.
Duprez D; Ferdinand K; Purkayastha D; Samuel R; Wright R
Vasc Health Risk Manag; 2011; 7():701-8. PubMed ID: 22174580
[TBL] [Abstract][Full Text] [Related]
4. Combination angiotensin-receptor blocker (ARB)/calcium channel blocker with HCTZ vs the maximal recommended dose of an ARB with HCTZ in patients with stage 2 hypertension: the exforge as compared to losartan treatment in stage 2 systolic hypertension (EXALT) study.
Wright RF; Duprez D; Purkayastha D; Samuel R; Ferdinand KC
J Clin Hypertens (Greenwich); 2011 Aug; 13(8):588-97. PubMed ID: 21806769
[TBL] [Abstract][Full Text] [Related]
5. Combination of angiotensin II receptor antagonist with calcium channel blocker or diuretic as antihypertensive therapy for patients with chronic kidney disease.
Ishimitsu T; Ohno E; Nakano N; Furukata S; Akashiba A; Minami J; Numabe A; Matsuoka H
Clin Exp Hypertens; 2011; 33(6):366-72. PubMed ID: 21797795
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and effects on lipid metabolism of combination treatment with losartan + hydrochlorothiazide versus losartan + amlodipine: a 48-week prospective, multicenter, randomized, open-label trial.
Nishiwaki M; Hosoai H; Ikewaki K; Ayaori M; Yamashita T; Shige H; Higashi K; Nashida Y; Shimizu S; Kijima F; Yokoyama M; Nakamura H;
Clin Ther; 2013 Apr; 35(4):461-73. PubMed ID: 23490288
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of amlodipine/olmesartan ± hydrochlorothiazide in patients uncontrolled on prior calcium channel blocker or angiotensin II receptor blocker monotherapy.
Neutel J; Shojaee A; Maa JF
Adv Ther; 2012 Jun; 29(6):508-23. PubMed ID: 22773358
[TBL] [Abstract][Full Text] [Related]
8. Prospective randomized study of the tolerability and efficacy of combination therapy for hypertensive chronic kidney disease: results of the PROTECT-CKD study.
Hayashi M; Uchida S; Kawamura T; Kuwahara M; Nangaku M; Iino Y;
Clin Exp Nephrol; 2015 Oct; 19(5):925-32. PubMed ID: 25680887
[TBL] [Abstract][Full Text] [Related]
9. Losartan/Hydrochlorothiazide: a review of its use in the treatment of hypertension and for stroke risk reduction in patients with hypertension and left ventricular hypertrophy.
Keating GM
Drugs; 2009 Jun; 69(9):1239-65. PubMed ID: 19537840
[TBL] [Abstract][Full Text] [Related]
10. Regression of Electrocardiographic Signs of Left Ventricular Hypertrophy by Combined Treatment With Thiazide Diuretic and Angiotensin-II Receptor Blocker.
Sawa T; Sato Y; Matsuda M; Tanaka M; Miyazaki S; Furukawa Y; Kita Y; Takatsu Y; Fujiwara H
Circ J; 2014; 78(11):2719-26. PubMed ID: 25273912
[TBL] [Abstract][Full Text] [Related]
11. Losartan/hydrochlorothiazide combination therapy surpasses high-dose angiotensin receptor blocker in the reduction of morning home blood pressure in patients with morning hypertension.
Hanayama Y; Uchida HA; Nakamura Y; Makino H
Acta Med Okayama; 2012; 66(6):449-59. PubMed ID: 23254579
[TBL] [Abstract][Full Text] [Related]
12. Comparison of medium-dose losartan/hydrochlorothiazide and maximal-dose angiotensin II receptor blockers in the treatment of Japanese patients with uncontrolled hypertension: the Kobe-CONNECT Study.
Toh R; Ishida T; Nishimura K; Nonaka H; Inoue Y; Kitagawa Y; Suematsu M; Miki T; Emoto N; Hirata K
Hypertens Res; 2012 Nov; 35(11):1080-6. PubMed ID: 22786569
[TBL] [Abstract][Full Text] [Related]
13. Combination of antihypertensive therapy in the elderly, multicenter investigation (CAMUI) trial: results after 1 year.
Sato N; Saijo Y; Sasagawa Y; Morimoto H; Takeuchi T; Sano H; Koyama S; Takehara N; Morita K; Sumitomo K; Maruyama J; Kikuchi K; Hasebe N;
J Hypertens; 2013 Jun; 31(6):1245-55. PubMed ID: 23492647
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin receptor blocker (ARB)-diuretic versus ARB-calcium channel blocker combination therapy for hypertension uncontrolled by ARB monotherapy.
Oshikawa J; Toya Y; Morita S; Taguri M; Hanaoka K; Hasegawa T; Kaizu K; Kamata K; Kobayashi S; Ohtake T; Sato T; Yasuda G; Kimura K; Umemura S
Clin Exp Hypertens; 2014; 36(4):244-50. PubMed ID: 23848219
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of the losartan-hydrochlorothiazide combination tablet in patients with hypertension uncontrolled by angiotensin II receptor antagonist therapy: the Aichi Research on Combination therapy for Hypertension (ARCH) Study.
Maeda K; Adachi M; Kinoshita A; Koh N; Miura Y; Murohara T
Intern Med; 2012; 51(10):1167-75. PubMed ID: 22687785
[TBL] [Abstract][Full Text] [Related]
16. Blood pressure response with fixed-dose combination therapy: comparing hydrochlorothiazide with amlodipine through individual-level meta-analysis.
Agarwal R; Weir MR
J Hypertens; 2013 Aug; 31(8):1692-701. PubMed ID: 23697963
[TBL] [Abstract][Full Text] [Related]
17. The effect of combination therapy on regression of left ventricular hypertrophy in cases with hypertension.
Boydak B; Nalbantgil S; Yilmaz H; Zoghi M; Ozerkan F; Nalbantgil I; Onder R
Saudi Med J; 2004 Dec; 25(12):1975-8. PubMed ID: 15711679
[TBL] [Abstract][Full Text] [Related]
18. The velocity of antihypertensive effect of losartan/hydrochlorothiazide and angiotensin II receptor blocker.
Metoki H; Ohkubo T; Kikuya M; Asayama K; Inoue R; Obara T; Hirose T; Sato M; Hashimoto T; Imai Y;
J Hypertens; 2012 Jul; 30(7):1478-86. PubMed ID: 22573119
[TBL] [Abstract][Full Text] [Related]
19. A 52-week prospective, cohort study of the effects of losartan with or without hydrochlorothiazide (HCTZ) in hypertensive patients with metabolic syndrome.
Racine N; Hamet P; Sampalis JS; Longo N; Bastien N
J Hum Hypertens; 2010 Nov; 24(11):739-48. PubMed ID: 20147971
[TBL] [Abstract][Full Text] [Related]
20. Effects of a combination of losartan and hydrochlorothiazide in patients with hypertension and a history of heart failure.
Kanda S; Yoshioka K; Amino M; Deguchi Y; Aizawa T; Tanabe T; Ikari Y
Tokai J Exp Clin Med; 2014 Mar; 39(1):1-4. PubMed ID: 24733590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
